The Relevance of Breast Cancer Subtypes in the Outcome of Neoadjuvant Chemotherapy

Author： Straver M.  

Publisher： Springer Publishing Company

ISSN： 1068-9265

Source： Annals of Surgical Oncology, Vol.17, Iss.9, 2010-09, pp. : 2411-2418

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Analysis of complete response by MRI following neoadjuvant chemotherapy predicts pathological tumor responses differently for molecular subtypes of breast cancer

By                            

Oncology Letters, Vol. 5, Iss. 1, 2013-01 ,pp. : 83-89

Spandidos Publications

Access to resources Recommend Favorite

Elevated thymidine kinase 1 in serum following neoadjuvant chemotherapy predicts poor outcome for patients with locally advanced breast cancer

By              

Experimental and Therapeutic Medicine, Vol. 3, Iss. 2, 2012-01 ,pp. : 331-335

Spandidos Publications

Access to resources Recommend Favorite

Downregulation of BCSG1 may correlate with better outcome of neoadjuvant chemotherapy for triple-negative breast cancer

By                  

Oncology Letters, Vol. 4, Iss. 6, 2012-01 ,pp. : 1209-1212

Spandidos Publications

Access to resources Recommend Favorite

[Corrigendum] Analysis of complete response by MRI following neoadjuvant chemotherapy predicts pathological tumor responses differently for molecular subtypes of breast cancer

By                            

Oncology Letters, Vol. 5, Iss. 4, 2013-01 ,pp. : 1433-1433

Spandidos Publications

Access to resources Recommend Favorite

Predictive Biomarkers in Breast Cancer: Their Value in Neoadjuvant Chemotherapy

By Fuksa L.   Micuda S.   Grim J.   Ryska A.   Hornychova H.  

Cancer Investigation, Vol. 30, Iss. 9, 2012-10 ,pp. : 663-678

Informa Healthcare

Access to resources Recommend Favorite